Advanced Oncotherapy PLC
LSE:AVO

Watchlist Manager
Advanced Oncotherapy PLC Logo
Advanced Oncotherapy PLC
LSE:AVO
Watchlist
Price: 1.925 GBX Market Closed
Market Cap: £9.1m

Cash Flow Statement

Cash Flow Statement
Advanced Oncotherapy PLC

Rotate your device to view
Cash Flow Statement
Currency: GBP
Dec-2006 Jun-2007 Dec-2007 Jun-2008 Dec-2008 Jun-2009 Dec-2009 Jun-2010 Dec-2010 Jun-2011 Dec-2011 Jun-2012 Dec-2012 Jun-2013 Dec-2013 Jun-2014 Dec-2014 Jun-2015 Dec-2015 Jun-2016 Dec-2016 Jun-2017 Dec-2017 Jun-2018 Dec-2018 Jun-2019 Dec-2019 Jun-2020 Dec-2020 Jun-2021 Sep-2021 Dec-2021 Jun-2022
Operating Cash Flow
Net Income
1
2
1
1
(2)
(3)
(2)
(3)
(4)
(3)
(7)
(7)
(3)
(3)
(4)
(7)
(6)
(7)
(6)
(7)
(10)
(12)
(14)
(18)
(21)
(21)
(21)
(22)
(25)
(26)
(21)
(29)
(33)
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
2
2
2
2
2
2
2
Other Non-Cash Items
(3)
(4)
(1)
(0)
2
4
3
2
4
4
7
7
2
2
1
1
(1)
1
(1)
(1)
(1)
(1)
(0)
2
6
6
2
4
7
3
7
10
14
Cash Taxes Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(3)
(4)
(2)
(2)
(3)
(3)
(2)
(2)
0
0
(2)
0
0
0
(0)
Cash Interest Paid
1
1
1
2
2
3
2
2
2
1
1
1
0
0
0
0
0
0
0
0
0
1
1
1
0
(1)
0
0
0
0
0
0
0
Change in Working Capital
0
0
(2)
(1)
(1)
(1)
(2)
(4)
(4)
(7)
(1)
2
(0)
(0)
(0)
1
(0)
(3)
(3)
(3)
(0)
0
4
16
13
(1)
(7)
(6)
(4)
(1)
(9)
(12)
(11)
Cash from Operating Activities
(2)
N/A
(1)
+23%
(1)
-9%
(1)
+50%
(1)
+10%
(0)
+30%
(1)
-68%
(4)
-453%
(4)
-5%
(5)
-27%
(1)
+86%
2
N/A
(1)
N/A
(1)
+9%
(3)
-135%
(5)
-54%
(7)
-45%
(8)
-29%
(10)
-17%
(11)
-14%
(11)
+3%
(12)
-11%
(10)
+21%
0
N/A
(2)
N/A
(14)
-771%
(24)
-62%
(21)
+10%
(20)
+5%
(22)
-7%
(22)
-1%
(30)
-34%
(27)
+8%
Investing Cash Flow
Capital Expenditures
(7)
(10)
(10)
(12)
(9)
(9)
(6)
(2)
(0)
0
(0)
0
(1)
(1)
(1)
(1)
(1)
(2)
(4)
(5)
(10)
(11)
(9)
(10)
(12)
(14)
(12)
(8)
(7)
(7)
(5)
(9)
(12)
Other Items
0
2
2
(0)
0
0
0
24
24
0
24
24
(0)
1
1
(0)
(0)
(0)
1
1
0
0
0
(0)
0
0
0
0
0
(1)
(2)
0
0
Cash from Investing Activities
(6)
N/A
(8)
-27%
(8)
-4%
(12)
-38%
(9)
+23%
(9)
+4%
(6)
+27%
21
N/A
23
+10%
0
-99%
24
+9 552%
25
+2%
(1)
N/A
0
N/A
1
+46%
(1)
N/A
(1)
-36%
(2)
-42%
(4)
-100%
(5)
-25%
(10)
-107%
(11)
-16%
(9)
+24%
(10)
-16%
(12)
-21%
(14)
-16%
(12)
+17%
(8)
+30%
(7)
+9%
(8)
-3%
(7)
+8%
(9)
-32%
(11)
-18%
Financing Cash Flow
Net Issuance of Common Stock
1
1
0
0
0
0
0
0
0
0
0
1
1
2
2
6
10
25
21
1
14
14
0
14
21
18
26
24
18
14
26
44
43
Net Issuance of Debt
2
4
6
8
14
12
5
(18)
(20)
5
(23)
(27)
1
(0)
0
(0)
(3)
(2)
0
0
(0)
9
16
(2)
(6)
12
12
8
10
11
1
(4)
(9)
Other
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
(0)
0
(0)
(0)
0
0
(1)
(1)
(1)
(1)
(1)
(1)
(0)
1
6
Cash from Financing Activities
3
N/A
5
+56%
6
+7%
8
+35%
14
+83%
12
-11%
5
-61%
(18)
N/A
(20)
-10%
5
N/A
(23)
N/A
(26)
-11%
2
N/A
2
-22%
2
+31%
6
+149%
9
+48%
25
+167%
21
-14%
1
-95%
13
+1 263%
23
+76%
17
-27%
13
-25%
15
+17%
29
+96%
37
+30%
32
-16%
27
-15%
24
-9%
27
+12%
41
+49%
40
-2%
Change in Cash
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
0
0
(0)
0
0
0
Net Change in Cash
(5)
N/A
(4)
+12%
(4)
-2%
(5)
-12%
4
N/A
3
-23%
(2)
N/A
(1)
+76%
(1)
+4%
(0)
+69%
(0)
+50%
0
N/A
0
+86%
1
+162%
0
-91%
1
+711%
1
+80%
14
+978%
7
-47%
(15)
N/A
(8)
+50%
(0)
+94%
(1)
-229%
3
N/A
1
-69%
0
-72%
2
+720%
2
-3%
(1)
N/A
(5)
-447%
(2)
+67%
2
N/A
2
-9%
Free Cash Flow
Free Cash Flow
(8)
N/A
(11)
-35%
(11)
-2%
(12)
-7%
(10)
+21%
(9)
+6%
(7)
+22%
(6)
+10%
(5)
+29%
(5)
-16%
(1)
+79%
2
N/A
(2)
N/A
(2)
-16%
(4)
-54%
(5)
-43%
(8)
-49%
(10)
-31%
(14)
-38%
(17)
-17%
(21)
-25%
(23)
-14%
(18)
+23%
(9)
+48%
(14)
-45%
(29)
-108%
(36)
-24%
(30)
+16%
(28)
+7%
(29)
-4%
(27)
+7%
(39)
-46%
(39)
+0%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett